Novo CEO pressed by Senate to cut price ranges of obesity, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the organization would think about new talks with insurers about the listing costs of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. Insurers will https://claytonxofvk.blogsvila.com/30795136/indicators-on-healthcare-news-you-should-know